SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-044402
Filing Date
2019-08-07
Accepted
2019-08-07 06:52:32
Documents
50
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-10375_110q.htm 10-Q 622597
2 EX-10.2 a19-10375_1ex10d2.htm EX-10.2 22966
3 EX-31.1 a19-10375_1ex31d1.htm EX-31.1 10936
4 EX-31.2 a19-10375_1ex31d2.htm EX-31.2 10944
5 EX-32.1 a19-10375_1ex32d1.htm EX-32.1 7256
12 GRAPHIC g103751bai001.jpg GRAPHIC 1497
  Complete submission text file 0001104659-19-044402.txt   2927728

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rarx-20190630.xml EX-101.INS 571666
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rarx-20190630.xsd EX-101.SCH 26266
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rarx-20190630_cal.xml EX-101.CAL 40778
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rarx-20190630_def.xml EX-101.DEF 63930
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rarx-20190630_lab.xml EX-101.LAB 255985
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rarx-20190630_pre.xml EX-101.PRE 172715
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37926 | Film No.: 191003771
SIC: 2834 Pharmaceutical Preparations